Success Metrics

Clinical Success Rate

100.0%

Based on 5 completed trials

Completion Rate

100%(5/5)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

17%

Ph phase_3

83%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution6 total trials

Phase 3Large-scale testing

5(83.3%)

N/ANon-phased studies

1(16.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(5)

Terminated(1)

Detailed Status

Completed5

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 3

Trials by Phase

Phase 35 (83.3%)

N/A1 (16.7%)

Trials by Status

completed583%

withdrawn117%

Recent Activity

0 active trials

Showing 5 of 6

withdrawnnot_applicable

Postprandial Lipidemia After a Meal With Different Types of Fat, Estrogen Treatment, Age and Gender in Healthy Subjects

NCT02383823

completedphase_3

Interest of Estrogen Scheduling Before Ovarian Stimulation With Corifollitropin Alfa

NCT02884245

completedphase_3

Clinical Trials (6)

Showing 6 of 6 trials

NCT02383823Not Applicable

Postprandial Lipidemia After a Meal With Different Types of Fat, Estrogen Treatment, Age and Gender in Healthy Subjects

Withdrawn

NCT02884245Phase 3

Interest of Estrogen Scheduling Before Ovarian Stimulation With Corifollitropin Alfa

Completed

NCT00000611Phase 3

Women's Health Initiative (WHI)

Completed

NCT00000549Phase 3

Estrogen Replacement and Atherosclerosis (ERA) in Older Women

Completed

NCT00000605Phase 3

Estrogen and Graft Atherosclerosis Research Trial (EAGER)

Completed

NCT00000601Phase 3

Postmenopausal Hormone Therapy in Unstable Angina

Completed

All 6 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 6